Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer

Pembrolizumab exposure-response assessments challenged by association of cancer cachexia and catabolic clearance

(2018) David Turner et al.   CLINICAL CANCER RESEARCH

Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes

(2018) Ryota Nakamura et al.   Journal of Thoracic Oncology

The Association between Red Blood Cell Distribution Width and Sarcopenia in U.S. Adults

(2018) Junghoon Kim et al.   Scientific Reports

Quantitative analysis of skeletal muscle by computed tomography imaging—State of the art

(2018) Klaus Engelke et al.   Journal of Orthopaedic Translation

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

(2017) Stefan Diem et al.   LUNG CANCER

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

(2017) Stephen J. Bagley et al.   LUNG CANCER

Connecting the Metabolic and Immune Responses to Cancer

(2017) Thomas R. Flint et al.   TRENDS IN MOLECULAR MEDICINE

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy

(2017) Yukihisa Yuri et al.   Journal of Cancer

Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery

(2016) N. Pecorelli et al.   BRITISH JOURNAL OF SURGERY

Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies

(2016) Shinya Okumura et al.   SURGERY

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

(2015) Hossein Borghaei et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan

(2012) Yoshimi Tanimoto et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

(2010) A. J. Cruz-Jentoft et al.   AGE AND AGEING

Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity

(2010) Suzanne Ostrand-Rosenberg   CANCER IMMUNOLOGY IMMUNOTHERAPY

Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”

(2010) M. Muscaritoli et al.   CLINICAL NUTRITION

The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity

(2010) Je-In Youn et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands

(2009) Jessica R Lieffers et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

Cachexia: A new definition

(2008) William J. Evans et al.   CLINICAL NUTRITION

Sarcopenic obesity: definition, cause and consequences

(2008) Sari Stenholm et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE